Analysis and data insight

Global spread of coronavirus puts financial markets into a tailspin

March 3, 2020

Concerns about the escalating global spread of COVID-19 panicked the markets big time at the close of the month. With investors rushing to the sidelines, it only took five days for the Dow Jones Industrial Average to drop more than 10% from its all-time high, getting close to the 30,000 mark.

Biocom Global Life Sciences Partnering Conference

Pharmas share their needs, wants and offer some advice

March 2, 2020

By Brian Orelli

No Comments

SAN DIEGO – At the Biocom 10th Annual Global Life Sciences Partnering Conference, panels of pharma executives highlighted what they're looking for to supplement their pipelines and offered advice that ran the gamut from company formation to the courting process to strategies for partnering pipeline drugs and platforms.

Week in review for Feb. 24-28, 2020: Two migraine therapies approved

March 2, 2020

By Peter Winter

No Comments

A quick look back at top stories, including: 1st Biotherapeutics, Acacia, Apeiron, Ascletis, Axovant, Bicycle, Biogen, Biohaven, Boehringer Ingelheim, Cocrystal, Curis, Glaxosmithkline, H. Lundbeck, Makscientific, MPM, NGM, Oramed, Pvp, Redhill, Roche, Sangamo, Shenzhen Xtalpi, Sichuan Clover, Steba, Takeda, Tetra, Tonix, Trutino, Twoxar, Vir, Wuxi.

Biopharma money raised: Jan. 1-Feb. 27, 2020

February 28, 2020

No Comments

Year-to-date money raised in public, private and other financings of biopharma companies.

Money raised by biopharma: 2020 vs. 2019

February 28, 2020

No Comments

Total raised in public, private and other financings of biopharma companies, comparing 2020 vs. 2019.

Collaborations between biopharmaceutical companies and government/nonprofit entities: January 2020

February 28, 2020

No Comments

Deals between biopharma companies and government or nonprofit entities, including: Actinium, Angiogenex, Axovant, Bellicum, Bicycle, Canonic, Celgene, Chongqing Zhifei, Cytovia, Decibel, Dinaqor, Diomics, Eagle, Ervaxx, G1, Gene Techno, Genentech, Genethon, Gilead, GSK, Horizon, Hoth, Medigene, Microcures, Moderna, Novartis, Oncotartis, Onxeo, Opiant, Orion, Sapphire, Tacitus, Titan, Valneva, Yposkesi, Zyus.

Collaborations between biopharmaceutical companies and government/nonprofit entities: February 2020

February 28, 2020

No Comments

Deals between biopharma companies and government or nonprofit entities, including: AB Biotics, ACT Genomics, Advent, Agex, Be Cool, Benevolentai, Beroni, Biomarin, Bridge, Chugai, CNS, Cocrystal, Dianomi, Enochian, Entourage Phytolab, Erytech, Evgen, Exicure, Genprex, Gibson Oncology, GSK, J&J, Novartis, Oncologie, Orgenesis, Sanofi Pasteur, Sapphire, Synspira, Theratechnologies, Toa Eiyo, VBL, WPD.

Analysis and data insight
RSS

Global spread of coronavirus puts financial markets into a tailspin

Pharmas share their needs, wants and offer some advice

Week in review for Feb. 24-28, 2020: Two migraine therapies approved

Biopharma money raised: Jan. 1-Feb. 27, 2020

Money raised by biopharma: 2020 vs. 2019

Collaborations between biopharmaceutical companies and government/nonprofit entities: January 2020

Collaborations between biopharmaceutical companies and government/nonprofit entities: February 2020

Biopharmaceutical grants: January 2020

Biopharmaceutical grants: February 2020

Biggest gainers and losers for the week of Feb. 24-28, 2020

Popular Stories

South Korea approves first four COVID-19 test kits under urgent-use license

Two South Korean COVID-19 kits look overseas, seek FDA approval

Noninvasive ventilation options explored for COVID-19, as FDA eases with guidance

Mallinckrodt to submit IND to FDA for inhaled nitric oxide to treat COVID-19 respiratory distress

FDA says yes to NO: Bellerophon Therapeutics wins expanded access approval for inhaled nitric oxide system

BioWorld Premium

Analysis and data insight RSS

Popular Stories

BioWorld Premium

Analysis and data insight
RSS